BLS Pharmaceuticals Limited (ASX:BLS)
Australia · Delayed Price · Currency is AUD 1.115
-0.025 (-2.19%)
Sep 2, 2026, 10:38 AM AEST
BLS Pharmaceuticals Market Cap
BLS Pharmaceuticals has a market cap or net worth of 262.17 million as of September 1, 2026. Its market cap has increased by 141.43% in one year.
Market Cap
262.17M
Enterprise Value
259.94M
Revenue
47.95M
Ranking
n/a
PE Ratio
28.72
Stock Price
1.12
ChartMarket Cap Chart
Since April 10, 2012, BLS Pharmaceuticals's market cap has increased from 31.38M to 262.17M, an increase of 735.49%. That is a compound annual growth rate of 15.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 262.17M | 180.50% |
| Dec 31, 2025 | 93.47M | 68.93% |
| Dec 31, 2024 | 55.33M | 164.50% |
| Dec 29, 2023 | 20.92M | 30.94% |
| Dec 29, 2022 | 15.98M | -13.94% |
| Dec 31, 2021 | 18.56M | 141.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 421.55M |
| Tetratherix | 367.54M |
| Starpharma Holdings | 340.95M |
| Orthocell | 205.55M |
| Nyrada | 205.09M |
| Dimerix | 165.11M |
| Actinogen Medical | 163.65M |
| Island Pharmaceuticals | 130.20M |